Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.2M Sell
695,820
-67,308
-9% -$3.92M 0.15% 136
2025
Q4
$41.2M Sell
763,128
-248,546
-25% -$12M 0.13% 137
2025
Q3
$45.6M Sell
1,011,674
-46,675
-4% -$2.18M 0.14% 111
2025
Q2
$49M Sell
1,058,349
-221,606
-17% -$10.9M 0.16% 102
2025
Q1
$78.1M Buy
1,279,955
+286,145
+29% +$16.7M 0.28% 62
2024
Q4
$56.2M Sell
993,810
-31,864
-3% -$1.78M 0.19% 78
2024
Q3
$53.1M Buy
1,025,674
+42,456
+4% +$1.99M 0.17% 101
2024
Q2
$40.8M Sell
983,218
-65,906
-6% -$2.95M 0.13% 108
2024
Q1
$56.9M Buy
1,049,124
+2,144
+0.2% +$109K 0.45% 53
2023
Q4
$53.7M Sell
1,046,980
-888,942
-46% -$46.7M 0.45% 52
2023
Q3
$112M Buy
1,935,922
+266,112
+16% +$16.3M 1.04% 16
2023
Q2
$107M Sell
1,669,810
-200,192
-11% -$13.4M 0.94% 18
2023
Q1
$130M Buy
1,870,002
+31,802
+2% +$2.24M 1.21% 11
2022
Q4
$132M Buy
1,838,200
+198,230
+12% +$14.9M 1.34% 8
2022
Q3
$117M Buy
1,639,970
+102,316
+7% +$7.42M 1.36% 8
2022
Q2
$120M Sell
1,537,654
-239,989
-14% -$18.3M 1.3% 11
2022
Q1
$131M Buy
1,777,643
+805,626
+83% +$54.1M 1.13% 16
2021
Q4
$60.8M Sell
972,017
-35,735
-4% -$2.1M 0.51% 41
2021
Q3
$59.6M Sell
1,007,752
-485,964
-33% -$32M 0.53% 39
2021
Q2
$99M Buy
1,493,716
+480,293
+47% +$31.3M 0.86% 22
2021
Q1
$64M Buy
1,013,423
+98,389
+11% +$6.12M 0.47% 27
2020
Q4
$55.1M Buy
+915,034
New +$56.3M 0.36% 40

Other funds holding BMY

Vontobel Holding's BMY Position: Q1 2026 in Review

Vontobel Holding reduced its Bristol-Myers Squibb (BMY) stake by 8.8% in Q1 2026, selling an estimated $3.92M and leaving 695,820 shares worth $42.2M. The position accounts for 0.15% of the portfolio, ranked #136.

Vontobel Holding first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $132M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Vontobel Holding held 695,820 shares of Bristol-Myers Squibb worth $42.2M as of Q1 2026.
  • Vontobel Holding sold 67,308 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.92M.
  • Bristol-Myers Squibb made up 0.15% of Vontobel Holding's portfolio in Q1 2026, its #136 holding.
  • Vontobel Holding first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Bristol-Myers Squibb position peaked at $132M in Q4 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.